This is the logo of the provider
ADA 2025 20 - 23 June 2025

Efficacy and Safety of Semaglutide 7.2 mg in Obesity and Type 2 Diabetes: The STEP UP T2D Trial

Authors :

Ildiko Lingvay1; Sara J Bergenheim2; John Buse3; Paula Freitas4,5; W. Timothy Garvey6; Nina M. Harder-Lauridsen2; Julio Rosenstock7; Kushal Sahu2; Sean Wharton8,9

Affiliations
View Details Hide Details
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Download poster (.pdf)
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)